Deafness reversed: One injection restores hearing in just weeks – ScienceDaily
Gene therapy has achieved a remarkable breakthrough, reversing congenital deafness in patients with a single injection targeting the OTOF gene. This pioneering study demonstrates rapid, significant hearing restoration, especially in younger individuals, marking a potential life-changer. Such impactful scientific advancements are highly valued by the Hacker News community for their future implications.
The Lowdown
A groundbreaking study published in Nature Medicine reveals that gene therapy can significantly improve or even restore hearing in individuals born with congenital deafness. Conducted by researchers from Karolinska Institutet in collaboration with Chinese hospitals, the trial involved ten patients and saw improvement in every case, with the therapy also proving to be well-tolerated.
- Targeted Approach: The therapy specifically addresses genetic deafness caused by mutations in the OTOF gene, which prevents the production of otoferlin, a protein crucial for transmitting sound signals.
- Single Injection: Researchers utilized a synthetic adeno-associated virus (AAV) to deliver a functional OTOF gene directly into the inner ear via a single injection.
- Rapid & Significant Results: Most patients began regaining hearing within one month, and all showed clear improvement after six months. On average, sound detection improved dramatically from 106 decibels to 52 decibels.
- Age Impact: Younger patients, particularly those between five and eight years old, experienced the most dramatic improvements, with one seven-year-old girl nearly fully regaining her hearing.
- Safety Profile: The treatment was deemed safe and well-tolerated, with no serious adverse reactions observed during the follow-up period; the most common side effect was a minor decrease in neutrophils.
- Future Expansion: The research team plans to expand this gene therapy approach to target other, more common genes associated with different types of deafness, building on promising animal study results.
This landmark research represents a significant leap forward in the genetic treatment of deafness, offering profound life-changing potential for countless children and adults and paving the way for broader applications in hearing restoration.